Estimation of prostate cancer volume by multiple core biopsies before radical prostatectomy

Urology

Volumn 52, Issue 4, 1998, Pages 653-658

  Egevad, Lars ^a,b   Norberg, Mona ^a   Mattson, Stefan ^a   Norlén, Bo Johan ^a   Busch, Christer ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TUMOR VOLUME;

ADULT; AGED; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROSTATECTOMY; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 0032189486     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00221-0     Document Type: Article

References (34)

1. McNeal JE, Villers AA, Redwine EA, et al: Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer 66: 1225-1233, 1990.
2. Stamey TA, McNeal JE, Freiha ES, et al: Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 139: 1235-1241, 1988.
3. Partin AW, Epstein JI, Cho KR, et al: Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J Urol 141: 341-345, 1989.
4. Villers AA, McNeal JE, Freiha FS, et al: Development of prostatic carcinoma. Morphometric and pathologic features of early stages. Acta Oncol 30: 145-151, 1991.
5. McNeal JE: Cancer volume and site of origin of adeno-carcinoma in the prostate: relationship to local and distant spread. Hum Pathol 23: 258-266, 1992.
6. Bostwick DG, Graham SJ, Napalkov P, et al: Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology 41: 403-411, 1993.
7. Epstein JI, Carmichael M, Partin AW, et al: Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol 149: 1478-1481, 1993.
8. Humphrey PA, Walther PJ, Currin SM, et al: Histologic grade, DNA ploidy, and intraglandular tumor extent as indicators of tumor progression of clinical stage B prostatic carcinoma. A direct comparison. Am J Surg Pathol 15:1165-1170, 1991.
9. Norberg M, Holmberg L, Wheeler T, et al: Five year follow-up alter radical prostatectomy for localized prostate cancer - a study of the impact of different tumor variables on progression. Scand J Urol Nephrol 28: 391-399, 1994.
10. Watson RB, Civantos F, and Soloway MS: Positive surgical margins with radical prostatectomy: detailed pathological analysis and prognosis. Urology 48: 80-90, 1996.
11. Lerner SE, Blute ML, and Zincke H: Risk factors for progression in patients with prostate cancer treated with radical prostatectomy. Semin Urol Oncol 14: 12-20, 1996.
12. Schmid HP, McNeal JE, and Stamey TA: Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume. Cancer 71: 2031-2040, 1993.
13. Terris MK, Haney DJ, Johnstone IM, et al: Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies. Urology 45: 75-80, 1995.
14. Stamey TA, Freiha FS, McNeal JE, et al: Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 71: 933-938, 1993.
15. Epstein JI, Walsh PC, Carmichael M, et al: Pathologic and clinical findings to predict tumor extent of nonpalpable (stage Tic) prostate cancer. JAMA 271: 368-374, 1994.
16. Hodge KK, McNeal JE, Terris MK, et al: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142: 71-74, 1989.
17. Stamey TA: Making the most out of six systematic sextant biopsies. Urology 45: 2-12, 1995.
18. Eskew LA, Bare RL, and McCullough DL: Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 157: 199-202, 1997.
19. Fleshner NE, and Fair WR: Indications for transition zone biopsy in the detection of prostatic carcinoma. J Urol 157: 556-558, 1997.
20. Lui PD, Terris MK, McNeal JE, et al: Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer. J Urol 153: 1000-1003, 1995.
21. Norberg M, Egevad L, Holmberg L, et al: The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 50: 562-566, 1997.
22. Norberg M, Holmberg L, Busch C, et al: Multiple transrectal ultrasound-guided biopsies for the detection of prostate cancer and determination of tumor volume, grade, and seminal vesicle invasion. Eur Radiol 6: 56-61, 1996.
23. Schmid HP, McNeal JE, and Stamey TA: Clinical observations on the doubling time of prostate cancer. Eur Urol 2: 60-63, 1993.
24. Crawlord ED, DeAntoni EP, and Ross CA: The role of prostate-specific antigen in the chemoprevention of prostate cancer. J Cell Biochem Suppl 25: 149-155, 1996.
25. Bostwick DG, Myers RP, and Oesterling JE: Staging of prostate cancer. Semin Surg Oncol 10: 60-72, 1994.
26. Babaian RJ, Troncoso P, Steelhammer LC, et al: Tumor volume and prostate specific antigen: implications for early detection and defining a window of curability. J Urol 154: 1808-1812, 1995.
27. Dietrick DD, McNeal JE, and Stamey TA: Core cancer length in ultrasound-guided systematic sextant biopsies: a preoperative evaluation of prostate cancer volume. Urology 45: 987-992, 1995.
28. Hammerer P, and Huland H: Systematic sextant biopsies in 651 patients referred for prostate evaluation. J Urol 151: 99-102, 1994.
29. Loch T, McNeal JE, and Stamey TA: Interpretation of bilateral positive biopsies in prostate cancer. J Urol 154: 1078-1083, 1995.
30. Peller PA, Young DC, Marmaduke DP, et al: Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens. Cancer 75: 530-538, 1995.
31. Cupp MR, Bostwick DG, Myers RP, et al: The volume of prostate cancer in the biopsy cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis. J Urol 153: 1543-1548, 1995.
32. Goto Y, Ohori M, Arakawa A, et al: Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies. J Urol 156: 1059-1063, 1996.
33. Irwin MB, and Trapasso JG: Identification of insignificant prostate cancers: analysis of preoperative parameters. Urology 44: 862-867, 1994.
34. Weldon VE, Tavel FR, Neuwirth H, et al: Failure of focal prostate cancer on biopsy to predict focal prostate cancer: the importance of prevalence. J Urol 154: 1074-1077, 1995.